A CRO works for more than one sponsor. Access should be an agreement both administrators sign, not a shared login. ValidTrials revokes that access by ending the guest sessions when the agreement ends.
Each sponsor organization stays separate until a collaboration is signed.
A starting study is a draft the client must still approve.
Visit reports and findings stay on the client’s study.
Budget lines and invoices are records with three different people for create, approve and pay.
The audience’s work is still the protocol, not a tour.
Turn on only what the study needs.
Scores and drafts do not approve anything.
A demonstration should use synthetic data.
It is in the product where the linked page says what the code does. Commercial packaging is a separate conversation.
We can show records and tests. We do not sign your validation for you.
Available with limitations means the described software behavior exists. A professional service is work a person does under a separate scope. Nothing here is a certification.
The conversation is about your study design and what the software can and cannot do today.
Clinical trial management for drugs, devices, and diagnostics. EU and US regulatory packages from one record. CAREPOI CRO, registered with EOF 16 November 2026.
© 2026 CAREPOI · ValidTrials · Helsinki, EU